Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Glaukos Corp (NY: GKOS ) 117.92 +0.50 (+0.43%) Streaming Delayed Price Updated: 9:36 AM EDT, Jul 2, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Glaukos Corp < Previous 1 2 3 4 5 6 7 Next > Glaukos to Release First Quarter 2023 Financial Results after Market Close on May 3 April 12, 2023 From Glaukos Corporation Via Business Wire Glaucoma Is The Second Leading Cause Of Blindness Globally – Skye Bioscience Appears To Be Making Rapid Progress In The Development Of Their Candidate To Treat It March 09, 2023 Biomed company Skye Bioscience (OTCQB: SKYE) has seen positive results in its clinical research so far and is preparing for the next stage in the development of its therapy for eye disease. Via Benzinga Glaukos Submits New Drug Application to U.S. FDA for iDose TR February 27, 2023 From Glaukos Corporation Via Business Wire NVIDIA To Rally Over 20%? Here Are 10 Other Analyst Forecasts For Thursday February 23, 2023 Goldman Sachs boosted the price target for Vir Biotechnology, Inc. (NASDAQ: VIR) from $41 to $53. Goldman Sachs analyst Paul Choi maintained a Buy rating on the stock. Vir Biotechnology shares rose... Via Benzinga Earnings Preview For Glaukos February 21, 2023 Via Benzinga Analyst Expectations for Glaukos's Future December 28, 2022 Via Benzinga 10 Analysts Have This to Say About Glaukos December 28, 2022 Via Benzinga Glaukos Announces Fourth Quarter and Full Year 2022 Financial Results February 22, 2023 From Glaukos Corporation Via Business Wire Glaukos Announces Participation in the Citi Healthcare Conference February 15, 2023 From Glaukos Corporation Via Business Wire Glaukos to Release Fourth Quarter and Full Year 2022 Financial Results after Market Close on February 22 February 01, 2023 From Glaukos Corporation Via Business Wire Glaukos Announces Positive Results for iDose TR Exchange Trial, Highlighting Favorable Safety and Tolerability January 10, 2023 From Glaukos Corporation Via Business Wire What 10 Analyst Ratings Have To Say About Glaukos December 28, 2022 Via Benzinga 7 Analysts Have This to Say About Glaukos December 12, 2022 Via Benzinga Analyst Ratings for Glaukos December 12, 2022 Via Benzinga Glaukos Announces Positive Clinical Updates for Several Corneal Health Pipeline Programs January 10, 2023 From Glaukos Corporation Via Business Wire Glaukos Announces Participation in the J.P. Morgan Healthcare Conference December 28, 2022 From Glaukos Corporation Via Business Wire Benzinga's Top Ratings Upgrades, Downgrades For December 22, 2022 December 22, 2022 Via Benzinga Skye Bioscience (OTCQB: SKYE) Heads Into 2023 As A Clinical-Stage Company After Dosing Its First Human Participants December 22, 2022 This year has been quite busy for Skye Bioscience Inc. (OTCQB: SKYE). Via Benzinga Where Glaukos Stands With Analysts December 12, 2022 Via Benzinga What 4 Analyst Ratings Have To Say About Glaukos November 03, 2022 Analysts have provided the following ratings for Glaukos (NYSE:GKOS) within the last quarter: Via Benzinga Needham Says Recent Launches To Drive Market Share Recovery For This Eye-Focused MedTech Stock October 04, 2022 Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For December 19, 2022 December 19, 2022 Via Benzinga Moderna To Rally Over 42%? Here Are 10 Other Price Target Changes For Monday December 19, 2022 Morgan Stanley cut VTEX (NYSE: VTEX) price target from $7 to $5. Morgan Stanley analyst Cesar Medina downgraded the stock from Overweight to Equal-Weight. VTEX shares fell 4.9% to close at $3.52 on... Via Benzinga Glaukos Announces Participation in the Stephens Annual Investment Conference November 07, 2022 From Glaukos Corporation Via Business Wire Benzinga's Top Ratings Upgrades, Downgrades For December 12, 2022 December 12, 2022 Via Benzinga Kellogg, Palo Alto Networks, Roku And Other Big Losers From Thursday November 04, 2022 U.S. stocks closed lower on Thursday, with the Dow Jones dropping more than 100 points. Here is the list of some big stocks recording losses in the previous session. Via Benzinga Glaukos Corporation Announces Third Quarter 2022 Financial Results November 02, 2022 From Glaukos Corporation Via Business Wire Glaukos to Release Third Quarter 2022 Financial Results after Market Close on November 2 October 12, 2022 From Glaukos Corporation Via Business Wire 10 Health Care Stocks Whale Activity In Today's Session September 29, 2022 This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... Via Benzinga Glaukos Technologies Featured in Numerous Scientific Abstracts at the 2022 American Academy of Ophthalmology Annual Meeting September 28, 2022 From Glaukos Corporation Via Business Wire < Previous 1 2 3 4 5 6 7 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.